Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
445 |
|
| Actual shortage: | 55 (12%) | |
| Anticipated shortage: | 14 (3%) | |
| Avoided shortage: | 8 (2%) | |
| Resolved: | 368 (83%) | |
Discontinuation Reports |
68 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (75%) | |
| Reversed: | 10 (15%) | |
Late reports |
44 (9%) |
|
Overdue reports |
14 (18%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-03-19 | 2020-08-05 | 109008 |
| RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-03-19 | 2020-08-05 | 109013 |
| ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2023-07-18 | 2023-10-23 | 198939 |
| RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2024-02-26 | 2024-04-04 | 220668 |
| OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Actual shortage | 2024-04-10 | 2024-04-11 | 224800 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
| DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
| DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
| MORPHINE SR | 15MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-04-08 | 2020-06-13 | 111515 |
| MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-04-08 | 111518 |
| MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-06-03 | 111521 |
| BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151302 |
| BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151307 |